Indeed, peritumoral injection of CRAMP (the mouse ortologe of LL-37) increased the mRNA expression of CXCL5, IL23A, MMP1, and MMP9 in B16F10 melanoma in vivo, suggesting that LL-37 could enhance pro-angiogenesis in melanoma. Here, MMP9 is linked to melanoma.